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Abstract A validated method for the simultaneous determi-
nation of prominent volatile cleavage products (CPs) of β-
carotene in cell culture media has been developed. Target CPs
comprised β-ionone (β-IO), cyclocitral (CC), dihydroactini-
diolide (DHA), and 1,1,6-trimethyltetraline (TMT). CPs were
extracted by solid-phase extraction applying a phenyl adsor-
bent, eluted with 10% (v/v)t e t r a h y d r o f u r a ni nn-hexane, and
identified and quantified by gas chromatography-mass
spectrometry with electron impact ionization. Method vali-
dation addressed linearity confirmation over two application
ranges and homoscedasticity testing. Recoveries from culture
media were between 71.7% and 95.7% at 1.0 μg/ml.
Precision of recoveries determined in intra-day (N=5) and
inter-day (N=15) assays were <2.0% and <4.8%, respective-
ly. Limit of detection and limit of quantification of the
analysis method were <18.0 and <53.0 ng/ml for β-IO, CC,
and TMT, whereas 156 and 474 ng/ml were determined for
DHA, respectively. Although extractions of blank matrix
proved the absence of interfering peaks, statistical
comparison between slopes determined for instrumental
and total method linearity revealed significant differ-
ences. The method was successfully applied in selecting
an appropriate solvent for the fortification of culture
media with volatile CPs, including the determination of
their availability over the incubation period. For the first
time, quantification of volatile CPs in treatment solutions
and culture media for primary cells becomes accessible
by this validated method.
Keywords β-carotene.Volatile cleavage products.Cell
culture media.SPE GC-MS.Validation
Introduction
Nutritional supplementation with vitamins is considered
an important issue in health provision thus gaining
increasing relevance in food industry [1, 2]. Within the
administered vitamin portfolio, β-carotene (BC), a pre-
cursor of vitamin A (retinol), has been ascribed a central
role in cancer prevention and therapy which is related to
the antioxidant property of carotenoids with their conju-
gated polyene structure predestined for free radical and
singlet oxygen scavenging [3]. Additionally, BC reduces
the risk of cardiovascular diseases, cataract development,
and macula degeneration. The outstanding quencher
function of BC advocates dietary supplementation [4–6].
BC accumulates in target organs, with highest concen-
trations in human liver and lung tissue [7]a n de n r i c h m e n t
in mitochondria and nucleus which are also considered
primary sites of effect [3, 8]. Causal relation between BC
supplementation and cancer protective effects has been
investigated recently in two comprehensive human inter-
vention trials, the ATBC [9] and the CARET study [10,
11], both providing a daily oral administration of 20–
30 mg BC [6]. Remarkably, BC-treated probationers with
long smoking history and/or asbestos exposition showed a
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increased mortality risk in comparison with placebo
controls. This required a premature abandoning of both
studies [9–12]. Concomitant chronic alcohol abuse en-
hanced toxic effects on hepatic level causing carcinogen-
esis [4, 9]. This apparent paradox has been related to pro-
oxidant and pro-carcinogenic properties of BC under
particular conditions, such as pronounced daily BC
supplementation in combination with high oxygen partial
pressure, oxidative stress, and high levels of reactive
oxygen species (ROS) all prevailing in lung tissues of
affected smokers [13–16].
Apparently, BC degradation products generated by
excentric (non-)enzymatic cleavage in the radical-rich lung
environment of smokers are responsible effectors, and these
cleavage products (CPs) may promote carcinogenesis in
manifold ways. In inflamed lung tissue, an increased
expression of marker proteins for cancer progression [17],
downregulation of tumor suppressors, and localized prolif-
eration of alveolar macrophages (orneutrophils) have been
observed [18]. Activated neutrophils release H2O2,O 2
−,
and myeloperoxidase (MPO), an enzyme which activates
(tobacco) pro-carcinogens [19, 20] but is also involved in
the formation of protein-, polysaccharide-, and DNA-
radicals leading to protein fragmentation, oxidation of cell
membranes, and DNA strand breaks, respectively [21–24].
Moreover, MPO catalyzes the formation of HClO from
H2O2 and Cl
− [21, 25], which induces BC degradation
towards non-volatile long chain CPs, e.g., aldehydes (so-
called apo-carotenals), epoxides, and carbonyls, but also
further to volatile short-chain CPs. These CPs can influence
the O2
− release of neutrophils and promote their apoptosis,
thus reducing clearance of cancer cells [3, 26]. CPs can also
induce enzymes of the cytochrome P450 family (CYP)
which activate pro-carcinogenic smoke constituents with
their successive binding to DNA [6, 13]. Subsequent
changes in cell growth and cell cycle induce a progression
of malignant effects [17, 18]. CYPs also induce increased
levels of ROS mainly in liver and lung [6, 13]. Conse-
quently, CPs seem to represent key triggers in the
development of latent tumors [6, 15].
Particularly, inflammatory effects may be highly
relevant for the generation of CPs and have been
s i m u l a t e di nv i t r ob yd e g r a d a t i o no fB Ci nH C l O
solutions of concentrations expected also under in vivo
conditions and the application of resulting CP mixture to
cell cultures. Such studies demonstrated not only an
impairment of mitochondria [3, 27] but also provided
clear evidence for genotoxic effects of CPs, i.e., treatment
of primary hepatocytes with CPs caused significant
increases of micronucleated cells, chromosomal aberra-
tions, and sister chromatid exchanges [28–30]. Although
profiles of resulting CPs were derived, concentrations of
the volatile CP species were not addressed, and their
quantification is missing [31].
Selected volatile target CPs have mostly been addressed
by gas chromatography-mass spectrometry (GC-MS) and
GC-ion trap-MS in the analysis of volatile odor causing and
aroma compounds in plants [32–34] and river water [35].
Applied clean-up and pre-concentration strategies com-
prised headspace solid-phase microextraction (HS-SPME)
[33, 34, 36], headspace co-distillation [32], simultaneous
distillation-extraction (SDE) [32, 37], stir bar sorptive
extraction [37], and purge-and-trap analysis [33] but also
liquid–liquid extraction (LLE) [31]. Recoveries and related
precision for selected CPs, if determined, were highly
variable depending on the analyte species and matrix [33].
GC-MS with off-line extraction was mainly applied for
compound profiling or semi-quantitative determination [31,
34, 36]. Some methods, such as SDE, are time and solvent
consuming and promote sample loss. Others, such as HS-
SPME or purge-and-trap, are highly efficient in extracting
volatiles but require equilibrium times between 60 and
120 min and increased temperatures of 35–50 °C. Extended
exposure times in combination with continuous heating and
open-air conditions increased the risk for artificial product
formation especially in the presence of complex mixtures of
reactive analytes and matrix compounds and might promote
oxidation of volatile organic compounds [32]. To the
knowledge of the authors, no validated methods for volatile
CPs of BC are available, especially for their determination
in cell cultures.
The presented work aims to optimize a GC-MS method
with previous off-line solid-phase extraction (SPE) for
clean-up applicable for the identification and quantification
of volatile CPs recently postulated as relevant degradation
products of BC, i.e., β-ionone (β-IO), cyclocitral (CC),
dihydroactinidiolide (DHA), and 1,1,6-trimethyltetraline
(TMT; Fig. 1)[ 31]. Due to the lack of some commercially
available CP standards, validated methods for these
volatiles are missing, consequently excluding standardiza-
tion of CP application solutions and quantification of CPs
in cell cultures. Based on recent results, cultures of primary
rat hepatocytes and pneumocytes have been selected as key
cellular models in the investigation of possible adverse
effects of CPs on the DNA level and thus their genotoxicity
[28–30]. Therefore, method optimization and validation has
to address equally application solutions and cell culture
media containing CPs. Although the current focus is on
volatile CPs, a parallel analysis of samples for volatile and
non-volatile CPs by GC-MS and LC-ESI-MS is a mid-term
objective. This approach will allow for both a true
standardization of CP application mixtures derived from
HClO degradation and quantification of volatile CPs in
culture media after incubation of cell cultures with
treatment solutions.
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Reagents and chemicals
CC (purity >90%) was obtained from SAFC (St. Louis,
MO, USA). TMT (purity 95%) was synthesized by VeZerf
Laborsynthesen GmbH (Idar-Oberstein, Germany). β-IO;
(purity >96%) was obtained from Alfa Aesar (Ward Hill,
MA, USA). DHA (purity >98%) was synthesized by
International Laboratory (San Bruno, CA, USA). Linalool
(Lin; purity >97%) and methylisoeugenol (Mie; purity
>98%) were purchased from SAFC and used as internal
standards (IS) due to the absence of commercially available
deuterated analytes. Tetrahydrofuran (THF; water-free and
without stabilizator) was from Merck (Darmstadt, Ger-
many). Methanol, n-hexane (in unisolv quality), minimum
essential medium Eagle (MEM), which was applied in cell
cultures, and Tween 20 were all purchased from Sigma
Aldrich (St. Louis, MO, USA). Ultrapure water was
prepared in a quality higher than 18.2 MΩ cm by a Milli-
Q Plus 185 system (Millipore S.A., Molsheim, France).
Gas chromatography-mass spectrometry
Analyses were performed on an Agilent HP-G1800A GCD
System coupled to an MS GDC Electron Ionization Detector
operatinginelectronimpactmodeapplying70eV.Thesystem
was equipped with a HP Automatic Liquid Sampler G1512
(all from Agilent Technologies, Palo Alto, CA, USA).
Automatic MS tuning was performed with perfluorotributyl-
amine (PFTBA) addressing 69, 219, and 502m/z.A n a l y t e s
and IS were separated on a DB-20 (WAX) capillary column
(30 m×0.25 mm, 0.50 μm film thickness) from Agilent.
Injector temperature and initial oven temperature were
260 °C and 65 °C, respectively. The oven temperature was
raised from 65 °C to 70 °C at a rate of 5 °C/min, then from
70 °C to 200 °C at a rate of 10 °C/min, maintained at 200 °C
for 4 min, raised further to 220 °C at a rate of 10 °C/min, and
finally maintained at 220 °C for 4 min. Detector temperature
was set at 320 °C all over the run. Helium was from SIAD
GmbH (Vienna, Austria) and used in a purity of 6.0 as a
carrier gas, applying a flow rate of 1.0 ml/min. A sample
volume of 1.0 μl was injected in splitless mode by means of
the autosampler. Solvent delay was set with 8.0 min. MS was
operated in scan mode (50–550m/z) for qualitative analysis,
testing the method specificity, screening of blanks, and
confirmation of compound identity. Compound identification
was based on matching experimental spectra with references
available from Wiley library (version 2005, Wiley, New
York, USA). Selected ion monitoring (SIM) mode was used
for quantitative analysis. For each analyte and IS, two ions, i.
e., the highest fragment (HF) for quantification and the
nominal mass (NM) as a control, were selected in the SIM
mode. Selected ions were also extracted from chromato-
grams recorded in scan mode and obtained from a combined
CP stock solution with both IS in order to confirm their
uniqueness. The selected ions (HF/NM) were 71/154m/z for
Lin, 137/152m/z for CC, 159/174m/z for TMT, 177/192m/z
for β-Io, 178m/z (HF and NM) for Mie, and 111/180m/z for
DHA (Fig. 2). Peak areas were integrated by MSD
ChemStation (v. D.03.00.611) and utilized for quantification
subsequent to their correction by both IS.
Standard solutions for GC-MS instrumental validation
A combined stock solution was prepared gravimetrically
in n-hexane containing all analytes and both IS at 100 μg/ml
a n ds t o r e di nd a r k n e s sa t−20 °C. From this stock
solution, standard solutions for calibration were freshly
prepared immediately prior to their use in GC-MS in
ranges of 1.0–50.0 and 0.5–4.5 μg/ml in n-hexane for
linearity testing.
      bp  boiling point (760 mm Hg) 
      log P log of octanol-water partition coefficient 
CP Mr bp  log  P 
CC 152.23  211°C  3.05 
β-Io  192.30 310°C  3.77 
TMT 174.28  242°C 5.25 
DHA 180.24  296°C 2.36 
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Fig. 1 Postulated degradation pathways of β-carotene by treatment
with HClO/ClO
− resulting in the formation of volatile target cleavage
products according to [31] including their relevant physicochemical
properties
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Solutions of 50 mmol/l Tween 20 containing all CPs and
Mie, which was applied as IS to correct for differences
in the SPE performance, at 20 mg/ml were dissolved in
MEM at a ratio of 1:200 (v/v) resulting in final
concentrations of 100 μg/ml of either CP and
0.25 mmol/l Tween 20. This working solution was
prepared immediately prior to SPE extraction and
employed for determination of SPE recoveries as well as
the inter- and intra-day precision of the finally selected
SPE phenyl adsorbent. For testing the SPE linearity, MEM
was spiked with the Tween 20-CP stock solution to give
nominal concentrations between 0.5 and 4.5 μg/ml for
each CP after extraction.
SPE extraction procedure
Strata-X 200 mg/3 ml, Strata-X-AW 200 mg/3 ml, Strata
CN 500 mg/3 ml, and Strata Phenyl 500 mg/3 ml SPE-
columns were obtained from Phenomenex (Torrance, CA,
USA) and applied in optimizing the SPE procedure. SPE
columns were conditioned with 3 ml methanol followed by
3 ml ultrapure water before 1.0 ml of the spiked MEM
working solution was loaded. The column was washed with
2 ml ultrapure water subsequently. Elution of CPs (and
Mie) was done by 2.0 ml 10% (v/v) THF in n-hexane at a
flow rate ≥2 ml/min. The eluate was frozen at −20 °C to
facilitate the separation of the organic and aqueous phase.
The hydrophobic fraction of the eluate was collected and
transferred to a 2-ml volumetric flask. After addition of Lin,
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Fig. 2 Chromatograms and MS spectra of CPs and IS. a Chromato-
gram for a CP standard solution (50 μg/ml of each CP dissolved in
10% (v/v) THF in n-hexane). b Chromatogram for CP standard
solution after SPE (expected concentrations for individual CPs
correspond to a. 1–6 MS spectra of CPs derived from a: 1 linalool
(IS), 2 cyclocitral (CC), 3 1,1,6-trimethyltetraline (TMT), 4 β-ionone
(β-IO), 5 methylisoeugenol (IS), and 6 dihydroactinidiolide (DHA)
2418 G. Martano et al.i.e., the IS for correcting the instrumental performance, and
adjustment of the final volume with n-hexane, the extract
was injected into GC-MS.
Treatment solution and CP solubility in cell culture media
To simulate cultivation conditions of primary hepatocytes
and pneumocytes, 5 ml MEM supplemented with non-
essential amino acids, pyruvate (1 mmol/l), aspartate
(0.2 mmol/l), serine (0.2 mmol/l), and penicillin (100 U)/
streptomycin (100 μg/ml) were placed in 60-mm diameter
plastic culture dishes with subsequent incubation for 3 h at
37 °C, 5% CO2, and 95% relative humidity. The optimiza-
tion of treatment solutions for primary cells addressed
solubility and stability of CPs over the incubation interval
testing THF and Tween 20 as suitable solvents. Appropriate
volumes of the treatment solutions with CPs either
dissolved in pure THF or in 50 mmol/l Tween 20 in
ultrapure water were spiked to MEM to achieve nominal
concentrations of 50 μg/ml for individual CPs after SPE,
respectively. Final contents of THF and Tween 20 in MEM
were 1.0% (v/v) and 0.25 mmol/l, respectively. Losses of
CPs were determined over 180 min incubation. Cytotoxic
concentrations of either solvent were determined in cell
cultures of primary hepatocytes or pneumocytes, which
were prepared from female Fischer 344 rats as outlined
elsewhere [38–40].
Statistical treatment
Statistical evaluation of data, e.g., analysis of variance
(ANOVA) and Welch test, was performed by use of the
SPSS Statistical Software Package version 16. Tests for
comparing slopes of regression equations and the Mandel’s
fitting test are not implemented in the standard operations
of SPSS. Thus, calculation algorithms were established by
employing the SPSS syntax function. When necessary,
details of calculation are specified in the respective section.
Results and discussion
The GC-MS method with preceding SPE was developed for
volatiles previously identified as relevant CPs of BC under
in vitro HClO degradation conditions as well as by
activated macrophages (Fig. 1)[ 31]. Currently applied
methods for determination of volatile CPs in cell cultures
are not validated and fail in their quantification but also in
standardizing application solutions. Both aspects are essen-
tial in geno- and cytotoxicity studies. Since some of these
volatiles have been postulated to be reactive especially in a
highly oxidative environment, e.g., in cell cultures exposed
to oxidative stress, the extraction procedure should be rapid
in order to depict the true analyte profile prevailing in the
culture media.
Instrumental validation of GC-MS
The in-house developed GC-MS method was subject of a
single-laboratory validation according to the IUPAC and
the relevant ICH guideline Q2(R1) [41, 42]. Instrumental
basis validation addressed intra-day and inter-day precision
of retention times (tr) and peak areas, linearity testing for
two concentration ranges, homoscedasticity testing, limit of
detection (LOD), and limit of quantification (LOQ). Peak
areas were corrected by IS for determination of precision
and linearity testing. All data were based on CP standard
solutions prepared in n-hexane including both IS. A
representative chromatogram including MS spectra of CPs
and both IS is given in Fig. 2.
Instrumental repeatability and inter-day precision
Repeatability (intra-day precision) for tr and corrected peak
areas were evaluated from five replicate injections of a 50-
μg/ml CP standard solution. The inter-day precision was
calculated from three replicate injections of this standard
solution on five different days. The respective intra- and
inter-day precision given as coefficient of variation (CV) for
corrected peak areas was from 0.20% to 0.57% and from
0.70% to 1.02%, respectively. Precision of tr was <0.03%
(CV) in either case.
Instrumental linearity
Calibration was done in the SIM mode and performed over
the GC-MS measurement step based on CP standard
solutions covering low and high concentration ranges, i.e.,
0.5–4.5 and 1.0–50.0 μg/ml, respectively. Six concentration
levels were evenly distributed over the tested range and
injected in triplicate, respectively. The low concentration
range refers to concentrations of volatile target CPs
produced, for example, by activated macrophages (data
not shown). Solutions derived from in vitro degradation of
BC in the presence of HClO and intended as standardized
CP mixtures for cell treatment have therefore also to cover
this concentration domain. The high concentration range
addressed concentrations of CP spiking solutions applied
for cell culture treatment in dose–response testing of
genotoxic effects. Calibration curves for both concentration
ranges were calculated for individual CPs by the least
square approach on the basis of peak areas corrected by IS.
Intercepts were tested by an ANOVA approach and were
neglected in case test results were not significant (Table 1).
Although coefficients of determination (R
2) were ≥0.995 in
either case, this cannot be considered an ultimate proof of
Analysis of cleavage products of β-carotene in cell cultures 2419linearity, but merely refers to the goodness of correlation
between corrected peak areas and related concentrations
[43]. Therefore, linearity was confirmed by Mandel’s fitting
test [43, 44]. Briefly, residual errors for a linear first-order
regression line and an alternative quadratic regression
model were calculated and compared by means of an F-
test at a statistical significance of 99%. For all concentra-
tion ranges and analytes, the calculated F value (Fcalc) did
not exceed the tabulated reference value (Ftab). Thus, none
of the tests was significant, which proved the validity of
linear response models, since quadratic modeling delivered
no improved data fitting. Furthermore, an ANOVA ap-
proach as available by SPSS was applied to evaluate the
linear regression model [45]. Both statistical strategies
provided corresponding results (Table 1).
Testing for homogeneity of variance
Additionally, calibration data were tested for absence of
heteroscedasticity, since this would entail the uncertainty of
analyticalresults to vary in a concentration-dependentmanner.
Homogeneity of variance was tested by analyzing standard
solutions of CPs (including IS) at concentration levels of 1.0
and 50.0 μg/ml by ten injection replicates, respectively. Fcalc
was derived by dividing the variance of the higher by the
variance of the smaller concentration. In all tested cases
Fcalc<Ftab (5.34), confirming homogeneity of variance over
the linear range at a 99.0% confidence level (Table 1)[ 44].
Instrumental limit of detection and limit of quantification
LOD and LOQ of individual analytes have to be
calculated from the standard deviation of signals derived
either from the noise of a blank or from low analyte
concentrations [41, 42]. LOD and LOQ both for the GC-
MS measurement step but also for the entire method (data
in subsequent section) were considered to address possible
differences. Instrumental LOD and LOQ were determined
from a combined CP standard solution of 0.5 μg/ml.
Baseline fluctuations required for the calculation of the
noise were recorded in SIM mode and determined over
time intervals equivalent to the twofold base peak width,
which were selected on either side of the respective CP
peak. LODs were calculated as the 3.3-fold of the standard
deviation of the noise divided by the slope of the
calibration curve for low concentrations (0.5–4.5 μg/ml)
for the respective CP. Naturally, this refers to a calibration
addressing signal heights. Again, linearity of these
calibration curves was confirmed prior to their application
in LOD calculation (data not shown). For reasons of
completeness, LOQ was calculated according to the ICH
guideline dividing the tenfold standard deviation of the
signal fluctuation of the noise by the slope of the
calibration curve for peak heights. DHA possessed the
highest LOD and LOQ of all CPs with 131 and 399 ng/ml,
respectively. LOD and LOQ of all other CPs were <18
and <53 ng/ml, respectively (Table 2).
Table 1 Validation parameters for calibration, linearity, and homoscedasticity testing for GC-MS and SPE GC-MS
CP Concentration range [μg/ml] Intercept (a) y=bx+aR
2 Linearity testing MFT
a,b ANOVA
b Homoscedasticity
p (for a)
c
CC 1.0–50.0 0 0.243 0.999 All passed All passed Passed
0.5–4.5 −1,251.483 <0.005 1.000 nd
SPE, 0.5–4.5 −797.665 <0.05 0.999 nd
TMT 1.0–50.0 595,460.831 <0.05 0.997 All passed All passed Passed
0.5–4.5 −4,044.633 <0.005 1.000 nd
SPE, 0.5–4.5 0 0.406 0.998 nd
β-IO 1.0–50.0 759,567.122 <0.05 0.995 All passed All passed Passed
0.5–4.5 2,654.717 <0.005 1.000 nd
SPE, 0.5–4.5 0 0.377 0.999 nd
DHA 1.0–50.0 0 0.185 0.998 All passed All passed Passed
0.5–4.5 0 0.055 0.999 nd
SPE, 0.5–4.5 0 0.356
d 0.999 nd
nd not determined
aMandel’s fitting test
bAt a confidence level of 99.0%
cRefers to the significance of the coefficient (intercept) defined in the regression analysis
dThe quadratic model gave slightly better fitting in case the intercept of the linear regression was considered. However, since the lowest concentration of
DHA was exactly the LOQ, it was prone to integration errors. With intercept considered an artifact in this particular case, linear regression provided better
fitting and is therefore considered the correct approach
2420 G. Martano et al.Appropriate solvents for cell culture treatment
The hydrophobicity of the volatile target CPs (Fig. 1)
required appropriate solvents to allow for a preparation of
CP solutions in sufficiently high concentrations to avoid
substantial changes in the composition of cell culture media
in the course of their fortification. Furthermore, the solvent
has to be miscible with the aqueous medium and should
preferably ensure (bio)availability over the incubation
period of 180 min as well as uptake of CPs by cells. For
this purpose, THF, a standard solvent for the application of
carotenoids, and Tween 20 were tested as solvents. Cells
were incubated in MEM spiked with increasing concen-
trations of THF and Tween 20. These controls were
compulsory to reveal possible onset of cytotoxic/genotoxic
effects. Culture media containing up to 0.5% (v/v) THF
induced no adverse effects at the cellular level. In case of
Tween 20, even at the highest tested concentration of
1.0 mmol/l, adverse effects were absent for both primary
hepatocytes and pneumocytes (data not shown).
Application to cell cultures
Losses of CPs from culture media without cells were
determined over the intended incubation duration of
180 min. For this purpose, MEM was spiked with CP
stock solutions prepared either in THF or Tween 20.
Aliquots of the media were analyzed immediately at
beginning of incubation and after incubation for 15, 30,
60, 120, and 180 min (Fig. 3). The reduction in CP
concentrations was more pronounced in culture media
spiked with CPs prepared in THF than in Tween 20. This
is most likely related to the volatility of THF, since major
CP losses were observed over the first 30 min, with a less
prominent reduction (for CC and TMT) and a quasi-stable
situation (for β-IO and DHA) afterwards. Losses within the
first half hour were CP specific, which is obviously related
to a combined effect of analyte volatility and hydrophobic-
ity. In this context, TMT showed the highest loss with only
3% of the initial amount persistent after 3 h (Fig. 3).
Although CC possesses a higher vapor pressure, its residual
amount was considerably higher which is due to its lower
hydrophobicity in comparison to TMT. Although the
hydrophobicity of β-IO was intermediate, it was less
affected than TMT and CC, which is due to its lower
volatility. Subsequent to an initial reduction, the DHA
concentration was maintained, clearly proving that the
observed initial loss is related to the solubility diminution
accompanying the THF evaporation but scarcely affected
by the analyte volatility itself. The high percentage of
remaining DHA was related to its high boiling point and
low hydrophobicity (Figs. 1 and 3).
The application of Tween 20 resulted in reduced losses
of all CPs, most evident for TMT. The reduction of β-IO,
CC, and TMT followed a linear trend over 120 min. Again,
TMT and CC showed highest losses, but more than 40% of
the initial amount was still present when incubation was
accomplished, whereas DHA remained nearly unaffected.
Contrary to THF, Tween 20 remained in solution over the
entire incubation interval. A comparison of both data sets
thus underpins more pronounced solubility losses of CPs
(probably in combination with evaporation) in THF due to
its release (Fig. 3). Both extended availability of CPs and
the lower toxicity of the solvent per se clearly proved
Tween 20 more appropriate for its application as solvent in
cell cultures than THF. Additionally, THF is known to form
peroxides in the presence of air and light and has increased
toxicity for certain cell lines. Moreover, recent data also
indicate promotion of tumor formation and an influence of
THF on P450 proteins, which would induce interfering
effects and aggravate unambiguous statements about CP
mechanisms [46].
Optimization of extraction
LLE has been used as a standard strategy in CP extraction
from cell cultures so far, although recovery data are missing
in literature [31]. Thus, in an initial approach, recoveries for
LLE were determined. Therefore, spiked MEM was
extracted with a threefold excess either of toluene or n-
hexane, modifying a method of Sommerburg et al. [31].
Recovery for either selected target CP was <10%. Conse-
quently, SPE was selected as an alternative to ensure a rapid
extraction process and prevent artificial product generation
in highly reactive mixtures over extended analysis time. A
pool of four different SPE phases, i.e., Strata-X, Strata-X-
AW, Strata CN, and Strata Phenyl, was selected for SPE
Table 2 Relevant parameters for basis validation including SPE,
LOD, and LOQ
Validation parameter CC TMT β-IO DHA
SPE 50 μg/ml (N=5)
Mean recovery, % 63.7 106.4 108.2 87.6
CV% (intra-day) 1.3 1.4 1.9 1.1
CV% (inter-day) 4.1 3.6 4.4 4.7
SPE 1.0 μg/ml (N=4)
Mean recovery, % 92.8 71.7 95.7 85.4
CV% (intra-day) 1.3 4.5 3.5 1.4
Instrumental (GC-MS)
LOD, ng/ml 17.2 3.4 8.2 131
LOQ, ng/ml 52.1 10.6 25.1 399
SPE GC-MS
LOD, ng/ml 17.4 4.6 11.2 156
LOQ, ng/ml 52.9 14.0 34.0 474
Analysis of cleavage products of β-carotene in cell cultures 2421optimization. However, Mie was not implemented for
recovery corrections at this stage to prevent artificial
distortions by possible variable adsorption of this IS to
different adsorbents (Fig. 4). Highest recoveries were
achieved with the reversed-phase phenyl stationary phase,
whereby extraction is primarily based on π–π interactions
available via the phenyl ring. Consequently, this stationary
phase is appropriate for extraction of aromatic hydrophobic
compounds such as TMT but also for hydrophobic
compounds with π-conjugated systems present in all target
CPs as well as BC itself.
Recoveries from model solutions with a nominal CP
concentration of 50 μg/ml after extraction were between
82% and 105% for β-IO, DHA, and TMT, which proves
the superiority of Strata Phenyl over all tested columns. CC
showed a slightly lower recovery of 67%. These high
recoveries were related to the compliance of several
essential extraction parameters. Samples have to be perco-
lated through the column at 2.0 ml/min or faster. For
elution, a THF content of 10% (v/v)i nn-hexane is required
since otherwise recoveries were reduced by more than 30%.
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2422 G. Martano et al.THF contents >10% (v/v) provided no increase in recovery.
Furthermore, a minimum elution volume of 2.0 ml is
recommended to ensure repeatable recoveries. In addition,
the residual water remaining in the SPE columns from the
previous loading of the aqueous sample interfered with the
final collection of the entire organic phase. Freezing the
eluate at −20 °C facilitated the complete transfer of the CP
containing n-hexane fraction.
Validation of SPE
Intra-day and inter-day precision of SPE recovery
The precision of SPE within single-laboratory validation
was determined at two levels, i.e., by (a) intra-day assay
which was based on five extraction replicates within 1 day
and (b) an inter-day approach based on three extractions
daily performed over five consecutive days, respectively. In
all cases, MEM was spiked with a CP stock solution
prepared in Tween 20 to give nominal analyte concen-
trations of 50 μg/ml in the eluates. Each eluate was
analyzed in triplicate by GC-MS. A representative chro-
matogram after SPE is given in Fig. 1b. Data were subject
to statistical evaluation for differences in variance by means
of a one-factor ANOVA. Since variances of recoveries were
not homogenous for β-IO and DHA over the tested period,
Welch test was additionally applied for confirmation. Both
tests were not significant for DHA and TMT, proving that
their fluctuations in recoveries were random. In case of CC
and β-IO, both tests indicated significant differences
between daily mean recoveries. However, it has to be
considered that the inter-day 95% confidence intervals of
recovery were exceptionally low (<2.7%). Furthermore, the
inter-day assay implements not only differences in the
actual extraction performance but also deviations related to
the extracted working solutions, which are prepared freshly
every day. Precisions of the entire method are expressed as
CV (Table 2).
Linearity of SPE recovery
Linearity testing of the entire analytical method considers
the independent preparation of CP working solutions and
SPE differences which might be related to CP concen-
trations but also to the individual extraction performance
of columns. The tested range was confined to the low
concentration domain previously addressed, thus cover-
ing CP concentrations expected in real samples but also
in in vitro degradation solutions of BC and CP solutions
intended for genotoxicity testing. Adequate to instrumen-
tal linearity, MEM working solutions spiked with CPs
and Mie were prepared at five concentration levels to
give nominally 0.5 to 4.5 μg/ml after SPE extraction.
Calculations of calibration curves were based on cor-
rected peak areas considering also a correction for the
actual recovery. Mandel’s fitting test and also ANOVA
proved linearity over the tested range and, except from
CC results for intercept testing, were not significant.
Therefore, a zero intercept was assumed for β-Io, DHA,
and TMT (Table 1).
Specificity
According to the IUPAC, selectivity is defined as the
degree to which a method can quantify the analyte
accurately in the presence of interferents [41]. Due to
the complex composition of culture media, the currently
unknown portfolio of products released by cells and the
possible elution of contaminants from SPE columns, a
single interferent testing—as proposed by the IUPAC—is
inapplicable. Instead, specificity was evaluated by extract-
ing a blank matrix (0.25 mmol/l Tween 20 in MEM),
which was collected after 3 h of incubation in the presence
of either primary hepatocytes or pneumocytes (without
and with bovine serum added to the respective cell
culture). For analytes and IS, retention time windows
were constructed based on the previously calculated
precision data to implement possible tr shifts in the
evaluation of specificity. No interfering peaks were
encountered at the tr of CPs and the internal standards
neither in SIM nor in scan mode (data not shown). In
addition, the slopes derived by the least square approach
both for the instrumental and the SPE calibration (compare
previous section) over the low concentration range were
compared for significance of differences. Briefly, this was
performed via a modified t-statistics, calculated by the
difference between both slopes divided by the standard
error of the difference between the slopes, with (N-4)
degrees of freedom [47]. For all CPs, significant differ-
ences were revealed between the slopes of respective
regression curves. Consequently, for CP quantification in
real samples, the instrumental regression equation has to
be replaced by the SPE-derived counterpart to avoid error-
prone results.
LOD and LOQ derived from SPE
Both LOD and LOQ were recalculated as described in
the instrumental validation, but by means of the slope
derived from the first-order linearity calibration function
for peak heights considering the entire SPE GC-MS
method. Linearity for peak heights in the low concentra-
tion range (0.5–4.5 μg/ml) was confirmed by Mandel’s
fitting test (data not shown). Derived LOD and LOQ
data were slightly higher than their instrumental counter-
parts (Table 2).
Analysis of cleavage products of β-carotene in cell cultures 2423Trueness
The trueness, which is quantitatively given by the bias,
refers to an accepted reference value derived from a
certified reference material or a reference method. Since
unfortunately none of these references is currently available
for the volatile target CPs in cell culture media, afore given
recovery data from spiked MEM have to serve as a
preliminary assessment of the bias [41].
Method application to cell cultures
The validated SPE GC-MS method was applied under cell
treatment conditions incubating hepatocyte cultures for 3 h
with a combination of all four volatile CPs covering 1.53 to
2.00 μg/mL for individual analytes (corresponding to
nominal 10 μM in the medium). These concentrations are
centered within the confirmed SPE linearity (Table 1).
Culture media with hepatocytes were analyzed prior to and
after accomplished incubation. Quantification of CPs was
based on the determined SPE linearity considering peak
areas corrected by internal standards. This way, aforemen-
tioned matrix effects were eliminated. After 3 h of
incubation, 5.0% to 47.4% of the initially applied amounts
were recovered for β-IO, CC, and DHA, whereas the
concentration of TMT was below the LOD (Table 3). The
observed reduction of CPs in the presence of cells had to be
corrected for volatility losses to derive cell-related uptake.
However, CP concentrations in hepatocyte cultures were
lower than those applied for monitoring evaporation-related
bioavailability (see Fig. 3). Therefore, evaporation losses
without cells had to be re-estimated after 3 h incubation for
the concentrations applied to hepatocytes in order to
prevent concentration-related mismatches. Recoveries of
CPs at 10 μM were between 50.9% and 83.5% of the
initially applied concentration in cell-deficient media
(N=4). The deviation from previous recovery data (Fig. 3)
was only 3.5–13.5% for β-IO, CC, and DHA. For TMT,
recovery was 25.2% higher with the lower concentration,
which might be concentration related. Consequently, the
pronounced reduction of CP concentrations encountered in
the presence of hepatocytes cannot be explained exclusive-
ly by evaporative losses. Therefore, residual amounts of
volatile CPs in hepatocyte cultures were corrected by
evaporative losses determined at equivalent CP concen-
trations to derive cell-related CP uptake. However, one has
to take into consideration that these data address a
presumed uptake and may actually comprise CPs entering
hepatocytes as well as CPs adhered to or incorporated into
plasma membranes. Furthermore, hepatocytes secrete pro-
teins, e.g., albumin, into the medium, which might also
interact with CPs [48]. However, at the current state, a
detailed distribution budget of CPs is beyond the scope of
this article. Evaporation and cellular uptake of CPs from
culture media are concurrent events. Consistently, corrected
CP data may reflect only the minimum cellular uptake/
adhesion over the incubation period (Table 3).
Conclusion
A GC-MS method with preceding SPE has been successfully
developed for the determination of volatile CPs of BC in cell
culturemedia.Therapidextractionintendstopreventchanges
Table 3 Hepatocyte cultures incubated with volatile CPs over 3 h
CC TMT β-IO DHA
CPs in cell culture prior to incubation (N=3)
Mean±95% CI (μg/ml)
a 1.53±0.09 1.77±0.01 1.85±0.11 2.00±0.61
CPs in cell culture after 3 h incubation
Mean±95% CI (μg/ml)
a
Dish 1 (N=3)
b 0.32±0.02 nd
c 0.14±0.01 0.94±0.30
Dish 2 (N=3) 0.31±0.02 nd 0.13±0.01 0.94±0.30
Dish 3 (N=3) 0.36±0.02 nd 0.14±0.01 0.83±0.26
Dish 4 (N=3) 0.35±0.02 nd 0.11±0.01 0.82±0.26
Remaining CPs (%) in medium after 3 h
d 18.0 nd 5.0 47.4
Cellular uptake/adhesion relative to initial concentration (%)
e 31.6 68.6 59.9 36.2
a95% confidence interval calculated from linear regression derived from SPE GC-MS
bN referring to replicate injections of the culture eluate derived from individual dish
cTMT concentration was smaller than LOD given in Table 1
dCPs recovered in cultures after 3 h incubation relative to initially applied concentrations calculated from corrected peak areas
eCP reduction corrected by evaporative losses, i.e., CPs recovered in cell-deficient media due to evaporation over 3 h incubation minus CPs recovered in
the presence of hepatocytes under identical incubation conditions and concentrations
2424 G. Martano et al.in the analyte profile due to possible conversions in a reactive
environment. Therefore, the method was validated for spiked
culture media. Recoveries were between 63.7% and 108.2%
and between 71.7% and 95.7% for all CPs at 50.0 μg/mL and
1.0 μg/ml, respectively. Intra-day and inter-day precisions of
the entire analytical method were determined <2.0%
and <4.8% (CV), respectively. Limits of detection were
between 4.6 and 156 ng/ml. Linearity was tested over a low
concentration range intended for monitoring cell culture
media as well as a high concentration domain for standard-
ization of treatment solutions. Both Mandel’s fitting test and
ANOVA confirmed linearity over the selected ranges. A
comparison of calibration slopes derived either from direct
injection of standard solutions or from spiked media which
passed through the entire method revealed significant differ-
ences for either analyte and indicated matrix effects. Conse-
quently, quantification has to be based on the regression
equation calculated for the entire method. The method has
also been employed to monitor CP availability for cells over
the incubation period and assisted in the selection of an
appropriate application solvent. The presented method allows
for the first time a quantitative determination of biologically
relevant volatile CPs of BC in in vitro cell systems. Future
strategies aim to quantify target CPs in differently treated cell
cultures and address their genotoxicity. Therefore, this
validated method represents a crucial pre-requisite for
revealing dose-dependent genotoxic effects either by treating
cell cultures of primary hepatocytes and pneumocytes with
individual or combined CP application solutions or by BC
degradation induced directly in the cell culture.
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